In addition to the routine treatment ( metformin ) , patients will receive a second drug orally for @ weeks : the METV group will receive metformin plus vildagliptin ( @ mg twice daily ) , and the METG group will receive metformin plus glibenclamide ( @ to @ mg twice daily . )